News

Digital Europe - first health-related calls are now open

Published on
| 4 years ago
Programmes
  • Health

The first calls under the Digital Europe programme have been opened on 17 November, the deadline to submit proposals is 22 February 2022. Under these calls, 3 call topics are health-related:

 

Further information and guidance on the Digital Europe programme can be found here. 

All open calls can be found on the Funding & Tenders Portal of the European Commission. 

Reference documents, including the Digital Europe 2021-2022 work programmes and the call documents, can be found here. 

Related news

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Latest news

2068 articles available Browse all news
  • Research Infrastructures
  • Health
  • Digital, Industry & Space
  • Climate, Energy, Mobility

Lasers4EU 6th Transnational Access programme for laser research and innovation

The Lasers4EU project consortium of research infrastructures provides access to state-of-the-art laser technologies and services from primary and secondary laser sources to a wide range of laser-based instruments and techniques at 27 leading laser research institutions across Europe. More information is available in their mission and on the...

Read more
  • Research Infrastructures
  • Digital, Industry & Space
  • Climate, Energy, Mobility

Ready-PV first call for Transnational and Virtual Access to Advanced PV Research Infrastructure

The READY-PV project consortium of research infrastructures (Reliability Evaluation Through Analytics and Data for Emerging Technology in Photovoltaics) opened its first call for Transnational Access (TA = on-site) and Virtual Access (VA = remote), providing the European photovoltaic research community with free-of-charge access to an integrated...

Read more

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.